These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25556912)

  • 21. The approved Italian version of the comprehensive assessment of at-risk mental states (CAARMS-ITA): Field test and psychometric features.
    Pelizza L; Paterlini F; Azzali S; Garlassi S; Scazza I; Pupo S; Simmons M; Nelson B; Raballo A
    Early Interv Psychiatry; 2019 Aug; 13(4):810-817. PubMed ID: 29696795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States.
    Yung AR; Yuen HP; McGorry PD; Phillips LJ; Kelly D; Dell'Olio M; Francey SM; Cosgrave EM; Killackey E; Stanford C; Godfrey K; Buckby J
    Aust N Z J Psychiatry; 2005; 39(11-12):964-71. PubMed ID: 16343296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Social defeat predicts paranoid appraisals in people at high risk for psychosis.
    Valmaggia LR; Day F; Garety P; Freeman D; Antley A; Slater M; Swapp D; Myin-Germeys I; McGuire P
    Schizophr Res; 2015 Oct; 168(1-2):16-22. PubMed ID: 26276306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal Cognitive Changes in Young Individuals at Ultrahigh Risk for Psychosis.
    Lam M; Lee J; Rapisarda A; See YM; Yang Z; Lee SA; Abdul-Rashid NA; Kraus M; Subramaniam M; Chong SA; Keefe RSE
    JAMA Psychiatry; 2018 Sep; 75(9):929-939. PubMed ID: 30046827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative and qualitative symptomatic differences in individuals at Ultra-High Risk for psychosis and healthy controls.
    Velthorst E; Derks EM; Schothorst P; Becker H; Durston S; Ziermans T; Nieman DH; de Haan L
    Psychiatry Res; 2013 Dec; 210(2):432-7. PubMed ID: 23938166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurocognitive predictors of transition to psychosis: medium- to long-term findings from a sample at ultra-high risk for psychosis.
    Lin A; Yung AR; Nelson B; Brewer WJ; Riley R; Simmons M; Pantelis C; Wood SJ
    Psychol Med; 2013 Nov; 43(11):2349-60. PubMed ID: 23388122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The history of childhood trauma among individuals with ultra high risk for psychosis is as common as among patients with first-episode schizophrenia.
    Sahin S; Yüksel Ç; Güler J; Karadayı G; Akturan E; Göde E; Özhan AA; Üçok A
    Early Interv Psychiatry; 2013 Nov; 7(4):414-20. PubMed ID: 23343404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adolescents at ultra-high risk for psychosis with and without 22q11 deletion syndrome: a comparison of prodromal psychotic symptoms and general functioning.
    Armando M; Girardi P; Vicari S; Menghini D; Digilio MC; Pontillo M; Saba R; Mazzone L; Lin A; Klier CM; Schäfer MR; Amminger GP
    Schizophr Res; 2012 Aug; 139(1-3):151-6. PubMed ID: 22627123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aripiprazole for drug-naive or antipsychotic-short-exposure subjects with ultra-high risk state and first-episode psychosis: an open-label study.
    Liu CC; Chien YL; Hsieh MH; Hwang TJ; Hwu HG; Liu CM
    J Clin Psychopharmacol; 2013 Feb; 33(1):18-23. PubMed ID: 23277261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychotic conversion of individuals at ultra-high risk for psychosis: The potential roles of schizotypy and basic symptoms.
    Bang M; Park JY; Kim KR; Lee SY; Song YY; Kang JI; Lee E; An SK
    Early Interv Psychiatry; 2019 Jun; 13(3):546-554. PubMed ID: 29218852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
    Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
    Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sources of clinical distress in young people at ultra high risk of psychosis.
    Rapado-Castro M; McGorry PD; Yung A; Calvo A; Nelson B
    Schizophr Res; 2015 Jun; 165(1):15-21. PubMed ID: 25890793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.
    Velthorst E; Nieman DH; Becker HE; van de Fliert R; Dingemans PM; Klaassen R; de Haan L; van Amelsvoort T; Linszen DH
    Schizophr Res; 2009 Apr; 109(1-3):60-5. PubMed ID: 19272756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Social environmental risk factors for transition to psychosis in an Ultra-High Risk population.
    O'Donoghue B; Nelson B; Yuen HP; Lane A; Wood S; Thompson A; Lin A; McGorry P; Yung AR
    Schizophr Res; 2015 Feb; 161(2-3):150-5. PubMed ID: 25439392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Individuals at ultra-high risk of psychosis and first-degree relatives of patients with schizophreniaexperience impaired family functionality and social support deficit in comparison to healthy controls.
    He XY; Hou CL; Huang ZH; Huang YH; Zhang JJ; Wang ZL; Jia FJ
    Compr Psychiatry; 2021 Aug; 109():152263. PubMed ID: 34274881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early psychotic experiences: Interventions, problems and perspectives.
    Dimitrakopoulos S; Kollias C; Stefanis NC; Kontaxakis V
    Psychiatriki; 2015; 26(1):45-54. PubMed ID: 25880383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulcogyral pattern and sulcal count of the orbitofrontal cortex in individuals at ultra high risk for psychosis.
    Lavoie S; Bartholomeuz CF; Nelson B; Lin A; McGorry PD; Velakoulis D; Whittle SL; Yung AR; Pantelis C; Wood SJ
    Schizophr Res; 2014 Apr; 154(1-3):93-9. PubMed ID: 24630136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Pre-onset Subthreshold Psychotic Symptoms With Longitudinal Outcomes During Treatment of a First Episode of Psychosis.
    Rosengard RJ; Malla A; Mustafa S; Iyer SN; Joober R; Bodnar M; Lepage M; Shah JL
    JAMA Psychiatry; 2019 Jan; 76(1):61-70. PubMed ID: 30304442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations between facial affect recognition and neurocognition in subjects at ultra-high risk for psychosis: A case-control study.
    Randers L; Jepsen JRM; Fagerlund B; Nordholm D; Krakauer K; Hjorthøj C; Glenthøj B; Nordentoft M
    Psychiatry Res; 2020 Aug; 290():112969. PubMed ID: 32450415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo.
    McHugh MJ; McGorry PD; Yuen HP; Hickie IB; Thompson A; de Haan L; Mossaheb N; Smesny S; Lin A; Markulev C; Schloegelhofer M; Wood SJ; Nieman D; Hartmann JA; Nordentoft M; Schäfer M; Amminger GP; Yung A; Nelson B
    Schizophr Res; 2018 May; 195():543-548. PubMed ID: 29055567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.